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ABSTRACT
C1
Cytokine measurement before and after hematopoietic stem cell transplantation
in severe diffuse systemic sclerosis
J-M Van Laar1, D Farge2, J Baraut2, F Jean-Louis2, EWN Romijn3, J van Pelt3, EWN Levarht3,
H Keshtmand2, F Verrecchia4 and L Michel2. 1Institute of Cellular Medicine, Newcastle University, UK;
2INSERMUMRS 976. Centre de Recherche sur la Peau. Hoˆpital Saint-Louis. Paris, France; 3Department
of Central Laboratories, Leiden Univ. Medical Centre, NL and 4INSERM U957, Nantes, France
Systemic sclerosis (SSc) is a heterogeneous autoimmune disease characterized by a wide
spectrum of microvascular and immunological abnormalities, leading to excessive collagen
deposition within the skin and internal organs. Several cytokines have been investigated as
possible mediators of fibrotic and vascular damage in SSc. Since 1996, we and others (1, 2) have
used high doses of cyclophosphamide followed by autologous hematopoietic stem cell
transplantation (HSCT) in several phase I-II studies to treat severe diffuse SSc, allowing complete
or partial remission in two thirds of the patients up to 7 years after HSCT. Our purpose was to
analyse the cytokine profile before and after HSCT in order to better understand the efficacy of
this therapy. Twenty severe diffuse SSc patients included in two similar phase I/II trials, using
uniform eligibility criteria and a single transplantation protocol (1), and 16 healthy subjects
(controls) were included. SSc skin fibrosis was assessed by repeated measure of the Rodnan
modified skin score. Patient sera were collected before (M0) and at M3, M6, M12, M24, M36 and
M48 months after HSCT. Representative endothelial markers, inflammatory and profibrotic
cytokines were measured with commercially available assays. HSCT induced a significant,
progressive and maintained reduction of the Rodnan modified score throughout follow-up, as
previously reported (1). Among endothelial markers, P-selectin levels were significantly higher in
serum from SSc patients before HSCT than in controls, and significantly decreased 2 years up to 4
years after HSCT. Other endothelial markers (ie E-selectin or VCAM-1) remained almost unaltered
throughout follow-up. Very low levels of IL-1b, IL-4, IL-10 and gIFN were detected before and
after HSCT. IL-2 and IL-8 were higher in SSc compared to control sera at M0, and both
dramatically reduced after 3 months. Il-8 was still decreased, while IL-2 progressively recovered
initial levels, 4 years post HSCT. Pro-fibrosis cytokines such as TGF-b1 were similar in SSc and
controls and not altered after HSCT. MCP1 and PDGF, significantly higher and lower in SSc than
in control sera at M0, respectively, were significantly decreased after HSCT throughout 4 year-
follow up. In conclusion, we identified quantitative changes in cytokine production in SSc after
HSCT, that might be related to clinical amelioration.
(1) van Laar JM, Farge D, Tyndall A. Ann Rheum Dis. 2008; 67 (S3):iii35–8.
(2) Vonk MC et al. Ann Rheum Dis 2008: 67: 98–104.
C2
The differential ability of human epidermal and CD14CD1cþ dermal dendritic
cells to prime naı¨ve CD4þ T cells involves the PD-L1/PD-1 pathway
I Briotet, A Journeaux, L Furio and J Pe´guet-Navarro. Universite´ de Lyon, EA 41-69, Pavillon R,
Hopital E. Herriot, Lyon, France
Dendritic cells (DC) are specialized antigen-presenting cells with the unique ability to initiate
primary T cell immune responses. Human skin contains distinct types of myeloid DC in the two
epidermal and dermal layers. Epidermal Langerhans cells (LC) have the langerin specific marker
whereas dermal dendritic cells (DDC) can be identified by the lack of CD14 and expression of
CD1 at the cell surface. However, few data are available regarding the respective role of these
cells in driving T cell immune responses. Here, we analyzed the relative capacity of human LC
and DDC to trigger naı¨ve CD4þT cell proliferation and differentiation. LC and DDC were purified
following a 2-day migration from the same skin sample. Migratory CD14CD1cþDDC displayed
less activated phenotype than LC (as evidenced by far lower expression of CD80, CD86, CD54,
CD40) and distinct expression of the new molecules of the B7 family: while LC expressed ICOS-L
(B7-H2) at stronger level than DDC, the expression of PD-L1 (B7-H1) was higher on DDC. As
expected, DDC displayed far lower allostimulatory property than LC, a process that was partly
reversed by the addition of anti-PD-L1 mAb in the culture medium. The capacity of LC and DDC
to polarize the differentiation of allogeneic naı¨ve CD4þ T cells was analyzed after a 7 day co-
culture. DDC were far less efficient than LC at inducing allogeneic naı¨ve CD4þ T cells to secrete
both Th1 (IFN-g, TNFa) and Th2 (IL-4, IL-5) cytokines. Moreover, addition of anti- anti-PD-L1
mAb increased the production of IFN-g by DDC-stimulated T cells, and to a lower extent by LC-
stimulated T cells. In conclusion, these results argue for a preponderant role of human LC in
inducing naı¨ve CD4þ T cell priming. The lower efficiency of CD14CD1cþDDC is partly related
to high expression of PD-L1 that down-regulates their ability to induce naı¨ve CD4þ T cell
proliferation and production of Th1 cytokines.
C3
Toll-like receptor-8 engagement on Artificial antigen-presenting cell-expanded
CD8þ T lymphocytes
J-F Chatillon1, C Abasq1, E Fauquembergue2, F Bayeux1, A Drouet2, J-B Latouche and P Musette1.
1Inserm U905 and 2Inserm U614, Rouen University-Hospital, Institute for Medical Research,
Cance´ropoˆle Nord-Ouest, Rouen, France. (J-FC and CA equally contributed to this work)
Adoptive transfer of in vitro activated and expanded tumor antigen-specific cytotoxic T
lymphocytes (CTLs) is a promising approach to cure cancer but numerous difficulties are
encountered. The main problem is to obtain highly cytotoxic cells that could home to the tumor.
Our team studied the impact of Toll-Like Receptor-8 (TLR8) engagement on peripheral CD8þ T
lymphocytes expanded by co-culture with artificial antigen-presenting cells (AAPCs, Latouche
and Sadelain, Nat biotechnol 2000). These AAPCs have been transduced to recreate a HLA-A2.1
immunological synapse which presents MART-1, an auto-antigen which is overexpressed in
melanoma, to CD8þ T cells. We defined the optimal conditions for obtaining MART-1-specific
CTLs from 6 A2.1þ healthy donors, using AAPCs and anti-MART-1 phycoerythrin (PE)-coupled
pentamer. After a 2–3 week co-culture, we obtained, in a donor-dependent manner, 3–25% of
specific CD8þ T cells. We found that CD8þ T cells expressed TLR8 at the cell surface and in
intracellular compartments. MART-1 specific T cells activated by TLR8 agonist (CL075) were able
to induce an increase of cytotoxic activity against MART-1-pulsed target cells, between 10 and
20% at each tested ratio for two donors, and at the highest ratio for two other donors. However,
TLR8 engagement did not change significantly the production of cytokines implicated in
cytotoxicity (TNF-a, IFN-g and Granzyme B). Here we confirmed the observation of Zarember
et al (2002) that TLR8 mRNA is present in CD8þ T cell population. Furthermore, we found that
TLR8 expression levels as well as the increase of cytotoxity observed after TLR8 engagement were
highly dependent on the donor. We could not correlate these effects with an increase of cytokine
production, and further analyses are needed to understand the mechanisms underlying the roles
of TLR8 engagement on CD8þ T cells.
C4
CD160 expression and release by human mast cells and basophils
C Ram-Wolff1, N Ortonne1,2, J Giustiniani4, M Bagot1,3, S Mecheri5 and A Bensussan4. 1INSERM
U841, faculty of medicine, Cre´teil; 2Department of Pathology; 3Dermatology, Henri Mondor
hospital, Cre´teil; 4INSERM U976, Saint-Louis hospital, Paris and 5Institut Pasteur, Paris, France.
CD160 is an immunoglobulin-like glycosyl phosphatidyl inositol (GPI)-anchored receptor,
expressed by cytotoxic lymphocytes. In NK lymphocytes, membrane-bound CD160 (trimeric
form) interacts with MHC class I molecules to trigger target cell lysis. CD160 is also cleaved and
released by a GPI-PLD and the soluble secreted protein was found to inhibit cell-mediated
cytotoxicity. A recent study showed that CD160 (a chimeric form similar to the dimeric form)
inhibits activation of human CD4þ T cells though interaction with herpesvirus entry mediator.
We searched CD160 expression in the human mast cells line HMC-1 and basophils cell line KU-
812 and in murine mast cells, using RT-PCR, flow cytometry analysis, immunoprecipitation and
immunoblotting of lysates and culture supernatants, immunohistochemistry on human and
murine samples. In HMC-1, CD160 expression was demonstrated at both transcript and protein
levels. Using Western blot, CD160 was detected in the culture supernatant of HMC-1 and KU-
812, indicating that mast cells and basophils release soluble CD160. We detected CD160 as
dimeric (40 kD) and trimeric (83 kD) form in these cells. In human and murine tissue samples,
immunostaining with anti-CD160 and anti-CD117/c-Kit antibodies showed co-localization of
both markers and a granular staining of CD160 in cytoplasm. In these cells CD160 could play a
role in the regulation of the innate and specific immunities: the trimeric form should regulate
cytotoxicity while the dimeric may inhibit activation of human CD4þ T cells.
C5
Contribution of the CD8þ and CD4þ T cells in the pathophysiology of the
allergic contact dermatitis to para-phenylenediamine
A Nosbaum1, A Rozie`res2, M Vocanson2, F Be´rard1, C Goujon3 and J Nicolas1. 1Unite´ d’Allergologie
et d’Immunologie Clinique, Centre Hospitalier Lyon Sud, Pierre Be´nite; 2Unite´ 851, INSERM, Lyon and
3Unite´ de Recherche Clinique en Immunologie, Centre Hospitalier Lyon Sud, Pierre Be´nite, France
Para-phenylenediamine (PPD) is responsible for allergic contact dermatitis (ACD) in hair dressers,
dye hair consumers and similarly after black henna tattoos application. This project aims to
identify the pathophysiological mechanisms inducing ACD lesions, by focusing on the
characterization of T lymphocytes responsible for the development of ACD to PPD. Two
approaches were used. An experimental murine model has shown that the development of ACD
to PPD doesn’t occur in normal mice, but only arises in mice depleted in CD4þ T cells,
suggesting that: (i) CD8þ T cells are effectors and (ii) CD4þ T cells contain regulatory/
tolerogenic cells. In humans, immunohistochemical analysis of the kinetics of T cell infiltration in
the PPD patch tests has revealed that the first T cell subset that infiltrate the skin are CD8þ Tc1
cells. These preliminary results raise the hypothesis that the pathophysiology of human ACD is
similar to that described in the mouse model, suggesting that CD8þ T cells are effector cells of
ACD to PPD and are under the control of CD4þ Treg cells. Ongoing studies aim at analysing
circulating PPD-specific CD8þ T cells and to develop therapeutic strategies to re-induce
tolerance to PPD in allergic patients.
C6
Epidermolysis bullosa acquisita associated with IgM paraproteins directed to
collagen VII and p200 pemphigoid antigen
S Mignot1, C Prost2, C Andre´3, F Aucouturier4, M Dandurand5, L Barrientos1, C Le Roux2,
L Laroche2 and F Caux2. 1Immunology, CHU Bichat; 2Reference Center for Bullous Diseases;
3CHU Mondor; 4CHU Saint Louis and 5Dermatology, Nimes; CHU Avicenne, Bobigny, France
Epidermolysis bullosa acquisita (EBA) and p200 pemphigoid are autoimmune bullous diseases
characterized by IgG antibodies directed to collagen VII and g1 laminin respectively. Here we report
an EBA patient with circulating IgM directed to 290kDa and 200kDa target antigens. A 63-year-old
woman presented with clinical features of classical EBA. Direct immunofluorescence (DIF) demonstrated
linear IgM and IgA deposits on skin basement membrane zone (BMZ). Immunoelectron microscopy
revealed IgG and IgM deposits on anchoring fibrils zone but also under lamina densa of vascular BMZ.
IIF showed high levels of IgM kappa directed to skin and dermal vessels BMZ and recognizing the dermal
side of salt split skin. Immunoblotting using amniotic extract demonstrated IgG, IgA and IgM directed to a
290kDa protein comigrating with collagen VII and IgM against a 200kDa protein. Two IgM paraproteins
(kappa predominant) of 22g/l with cryoglobulinemia activity were present. Several features are unusual
in this case report: (i) EBA is associated to IgM directed to collagen VII, (ii) IgM antibodies recognized a
200kDa protein which may be g1 laminin as suggested by vessel BMZ staining, and (iii) monoclonal IgM
may have specific activities directed against two different BMZ antigens. This observation is the first with
IgM directed against p200 pemphigoid antigen and the second of IgM EBA. Moreover it suggests that IgM
paraproteins may have specific affinity for cutaneous BMZ epitopes.
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C7
Absolute CD3þCD158kþ lymphocyte count is reliable and more sensitive than
cytomorphology to evaluate blood tumor burden in Sezary syndrome
J-D Bouaziz, N Remtoula, A Marie-Cardine, A Bensussan and M Bagot. Inserm U976, Paris 7
University, Skin Research Center, Saint Louis Hospital, Paris, France
CD158k/KIR3DL2 is a sensitive and specific marker for Sezary cells which can be used to
diagnose Sezary syndrome (SS) in erythrodermic patients having abnormal circulating T cells. The
goal of this study was to evaluate the interest of CD158k/KIR3DL2 in detecting and evaluating
blood tumor load during the follow up of SS patients. The absolute CD3þCD158kþ lymphocyte
count was compared to the absolute count of cytomorphologic Sezary cells and was correlated to
clinical flares in a cohort of SS patients. Twenty-five patients were included in the study and 48
blood samples were analysed. The absolute count of CD3þCD158kþ cells strongly correlated
the absolute count of atypical circulating cells (r¼ 0.97, Po1015). CD3þCD158kþ lymphocyte
cell count was in 8 cases more sensitive than cytomorphology to detect atypical circulating cells
especially for small-sized tumor cells. The tumor burden evaluated by CD3þCD158kþ
immunostaining was significantly associated to clinical flare up (Po104). Thus,
CD3þCD158kþ phenotyping is a reliable and objective test to monitor the blood tumor burden
in SS patients under systemic therapy.
C8
Involvement of dermokine d, a new partner of RAB5, in the endovesicular traffic
E Leclerc, L Gazeilles, E Toulza, G Serre, M Guerrin and N Jonca. UMR 5165 UDEAR – CNRS/
UPS – Toulouse, France
To identify the lately expressed genes in human epidermis, we analysed the transcriptome of
granular keratinocytes. Surprisingly, one of the most represented gene encodes dermokine
(DMKN), a protein with unknown function. We identified 4 groups of transcripts: the secreted a, b
and g isoforms share an epidermis-restricted expression pattern, whereas the d isoform is
intracellular and ubiquitous. We used the yeast two-hybrid system to identify DMKNd partners.
Protein interactions were further analyzed in vitro by GST pull-down experiments and in vivo by
transfection and immunolocalization in HEK293 and HeLa cells. We identified the small GTPases
RAB5 as partners for DMKNd. The RAB5 proteins regulate membrane docking and fusion in the
early endocytic pathway. Like other GTPases, they cycle between an inactive (GDP-bound) and
an active (GTP-bound) state. We showed in vitro and in vivo that DMKNd is able to bind both the
active and inactive forms of RAB5b. Moreover, ectopic expression of GFP-tagged DMKNd in
HeLa cells leads to formation of vesicles that colocalize partially with endogenous RAB5, and
with other vesicle markers of the endocytic pathway (Clathrin, RAB7 and LAMP1). We are
currently analyzing the nature of these vesicles by transferrin uptake experiments. This work
suggests a role for DMKNd in the vesicular traffic. Indeed, RAB5 interacts with many partners that
regulate its function or act as effectors. Experiments in progress will help determining the impact
of DMKNd on RAB5 function, its possible interaction with other RAB proteins close to RAB5, and
the underlying molecular mechanisms.
C9
Single-cell analysis of radiation-induced damage on human epidermal keratino-
cyte stem cells and progenitors
N-O Fortunel, E Cadio, P Vaigot, S Moratille and M-T Martin. CEA/iRCM/LGRK, 91057 Evry,
France
Epidermis is the first target of external irradiation received for therapeutic or diagnosis purposes.
The basal layer is particularly important for skin carcinogenesis, as it contains both stem cells and
progenitors. We developed a new method that allows multi-parallel clonal cultures of
keratinocytes. Immediately after extraction from tissue samples, basal cells are sorted by flow
cytometry based on their high integrin-a6 expression and plated individually in microculture
wells. At the end of the primary culture (14 days), the distribution of clone size, which ranged
from abortive clones to highly proliferative clones, was well representative of the hierarchical
organisation of the basal layer. In long-term cultures, some highly proliferative clones could
sustain extensive expansion (150 population doublings [PD] over 25 weeks) and exhibited
epidermis reconstruction potency, thus fulfilling stem cell functional criteria. Thus, this system
was particularly relevant to generate precisely characterized cell samples corresponding to the
clonal progeny of stem cells or progenitors. We have then used the clonal microculture system to
analyze the short- and long-term consequences of an exposure of basal keratinocytes to a single
2 Gy dose of ionizing radiations (g rays). Radiation exposure caused a marked increase of the
frequency of abortive clones. Transmission of genomic abnormalities to the progeny of resistant
clones was investigated using comparative genome hybridization (CGH) arrays. This approach
revealed specific aberrations, including duplications of genomic loci. In conclusion, the single-
cell method appeared efficient to explore the effects of a clinically relevant dose of irradiation.
C10
Ifapsoriasin but not hornerin colocalizes with filaggrin in normal human
epidermis
J Henry1, C-Y Hsu1, S Balica2, J Mazereeuw-Hautier2, C Jean-Decoster, A-M Schmitt3, C Paul2,
G Serre1 and M Simon1. 1UMR5165, CNRS-University of Toulouse III; 2Department of
Dermatology, Purpan Hospital and 3Pierre Fabre Dermo-Cosme´tique, Toulouse, France
Hornerin and ifapsoriasin (filaggrin-2), two proteins encoded on chromosome 1q21, share
numerous common features with filaggrin, a key protein implicated in the epidermal barrier
functions. They display the same introns-exons organisation, a similar amino acid composition
and a related structural organisation, suggesting functional redundancy. However, their
localization and role are still unclear. To analyse their expression in normal human epidermis,
we produced polyclonal anti-peptide antisera in rabbits. The specificity of the affinity-purified
antibodies was demonstrated by immunodetection of the recombinant proteins, and by
competition assays with synthetic peptides. In epidermis extracts, hornerin was detected as a
large immunoreactive smear, and ifapsoriasin as both high and low molecular weight products.
This is consistent with processing of a polypeptide precursor, as previously observed with
filaggrin. Immunohistochemical and confocal microscopy analysis of skin cryosections and
paraffin-embedded formalin-fixed skin sections showed specific patterns of expression. Hornerin
was localized both in the upper granular layer partially colocalizing with profilaggrin, and in the
whole cornified layer at the corneocyte periphery. Ifapsoriasin colocalized with filaggrin in both
the granular and the lower cornified layers. Immunodetection using superficial stratum corneum
extracts obtained by tape-stripping confirmed the presence of hornerin only. Its similarities with
filaggrin make ifapsoriasin a good candidate for contribution to cornified layer barrier functions.
C11
MC1R expression in HaCaT keratinocytes inhibits UVA-induced ROS production
via a cAMP dependent mechanism and stimulates NoxA1 phosphorylation
P Henri1, A Guezennec2, C Poume`s2, P-E Stoebner1, J Martinez1, J Guesnet2 and L Meunier1.
1UMR-CNRS 5247 Montpellier and 2YSL R&D, Neuilly-sur-Seine, France
Ultraviolet (UV) light activates Nox1-based NADPH oxidase to produce reactive oxygen species
(ROS) and induces melanocortin-1 receptor (MC1R) in keratinocytes. To investigate the effects of
MC1R signalling on UVA-induced ROS production in keratinocytes we generated HaCaT cell
lines that stably express the wild type (HaCaT-MC1R) or the non functional variant Arg151Cys
(HaCaT-R151C) of the human MC1R gene. Basal level of cAMP was higher in HaCaT-MC1R
tested clones. Compared to wild type HaCat (HaCaT wt) and HaCaT-R151C cells UVA and UVB
exposure of HaCaT-MC1R cells resulted in a dose-dependent decrease of ROS production that
was further amplified by a-MSH pre-incubation. The UVA-induced decrease of ROS production
was abolished by pre-treatment of HaCaT-MC1R cells with the protein kinase A inhibitor H-89.
Forskolin incubation of HaCaT wt and HaCaT-R151C cells resulted in an inhibition of ROS
similar to that observed in UVA-exposed HaCaT-MC1R cells. UVA exposure of all tested cell lines
did not induce mitochondrial ROS (mROS). Apocynin inhibition of NADPH oxidase was more
effective in HaCaT wt and HaCaT-R151C cells than in HaCaT-MC1R cells. Phosphorylation of the
regulatory subunit Nox activator-1 (NoxA1) of Nox1 was enhanced in HaCaT-MC1R cells
compared to that of HaCaT wt and HaCaT-R151C cells. Our findings suggest that MC1R
expression in HaCaT cells inhibits UVA-induced oxidative stress by reducing the activity of Nox1
via a cAMP dependent mechanism.
C12
Compartmentalization of the human stratum corneum (SC) by persistent tight
junction (TJ)-like structures
S Callejon, Y Sandjeu, J Brandner* and M Haftek. Universite´ Lyon 1, CNRS, Lyon, France and
*Department of Dermatology and Venerology, University Hospital Hamburg, Germany
Tight junction proteins are expressed in human adult epidermis. Structures characteristic of TJ
have been detected in freeze-fracture studies at the top of the granular layer. We used
transmission electron microscopy in search for additional hints indicating the presence and
localization of TJ between keratinocytes. Jejunal epithelium served as a control for studies on
adult human skin biopsies, embedded in Epon and Lowicryl resins, using antibodies to claudin-1
and occludin. We detected discrete points of contact persisting in the lower horny layers,
suggestive of a molecular fusion within the structures. This phenomenon concerned 69% of the
apico-lateral contacts visualized between corneocytes of the SC compactum. Also, cornified cell
envelopes isolated from the SC and embedded in Lowicryl K4M showed focal reactivity with
antibodies to claudin-1 and, to a lesser degree, to occludin. We suggest that TJ-like structures
distributed at the periphery of the flattening corneocyte disks are entrapped in the cross-linked
cell envelopes and contribute to the vertical delimitation of successive extracellular compart-
ments in the SC. This observation supports our idea that preferential degradation of the ‘‘central’’
versus ‘‘peripheral’’ corneodesmosomes could be due to a specific compartmentalization of the




Peptidylarginine deiminases are differently up-regulated as evidenced using
keratinocyte differentiation models
M-C Me´chin1, F Coudane1, V Adoue1, J Arnaud1, H Duplan2, M Charveron2, A-M Schmitt2,
H Takahara3, G Serre1 and M Simon1. 1UMR5165, CNRS-University of Toulouse III, Toulouse,
France; 2Pierre Fabre Dermo-Cosme´tique, Toulouse, France and 3Department of Applied
Biological Resource Sciences, University of Ibaraki, Ibaraki, Japan
Peptidylarginine deiminases (PADs) catalyze the deimination of proteins, converting arginyl
residues to citrullyl residues. Among the five PADs, only PAD1-3 have been detected in normal
human epidermis, with different locations and substrate specificities. Their major target is
filaggrin, a key protein for maintaining an effective epidermal barrier against the external
environment. To investigate the regulation of deimination in keratinocytes, we used two
differentiation models: treatment with vitamin D (107 M) and increasing cell-density. PAD1-3
mRNAs were induced by vitamin D, with distinct kinetics of induction, but without any
consequences on either the protein levels or the deimination rate, suggesting an additional post-
transcriptional regulation. High cell-density increased PAD1 and 3, but not PAD2, at the mRNA
and protein levels, and up-regulated the protein deimination level by a factor of twelve. We also
showed that auto-deimination reduces PAD activity on filaggrin and might be an additional level
of regulation of the enzymes. Using topological three-dimensional models of PAD3, based on the
structure of PAD4, we showed that in silico substitution of the most accessible arginines by
citrullines increases the distance between the amino-acids of the active site. Our data
demonstrate that PADs and deimination are regulated at multiple levels: transcription, translation
and enzymatic activity.
C14
Interaction of melanoma cells, fibroblasts and the extracellular matrix
D Seidler1 and C Stock2. 1Institute of Physiological Chemistry and Pathobiochemistry and
2Institute of Physiology, UKM, Universtiy Mu¨nster, Germany
Introduction: Metastasis of melanoma cells requires their migration through the extracellular
matrix (ECM) of the dermis. Migration through the dermis is determined by cell-matrix and cell-
cell interactions. To study the influence of the ECM and fibroblasts on migration/invasion we
established a cell co-culture model which contains fibroblasts, their collagen-rich matrix and
melanoma cells. Material & Methods: Mouse-fibroblasts were cultured for 14 days in presence of
ascorbate-2-phosphate. The generated 3D matrices were used for the co-culture with mouse
melanoma cells (B16). B16 cells were either trypsinised or EDTA-treated and used for migration
on the fibroblast matrices. Migration was monitored by time lapse video microscopy for up to
12 hours. Furthermore, the effects of (i) the NHE-1 inhibitor HOE 642, (ii) decorin and (iii) several
glycosaminoglycans on migration were investigated. To determine the crosstalk between B16 and
fibroblasts we analysed the MMPs by zymograms and Western blot (MMP-2). Results: With this
co-culture model it is possible to determine the velocity of EDTA-treated B16 cells which are
4 times higher compared to trypsinised cells. The treatment of B16 cells with HOE inhibits the
migration velocity under both conditions. Interestingly, decorin has the same effect as HOE. Both
reduce the amount of MMP-2 in the co-culture system compared to the untreated system. In
addition to the cells migrating on the ECM invasive cells could be detected inside. We show
a feasible model to study the behaviour of melanoma cells in vitro.
C15
Lumcorin: a leucine-rich repeat 9-derived peptide from human lumican inhibiting
melanoma cell migration
C Zeltz1, S Bre´zillon1, C Perreau1, J Heino3, CM Franz4, F-X Maquart1,2 and Y Wegrowski1.
1Laboratoire de Biochimie Me´dicale et de Biologie Mole´culaire, CNRS UMR 6237, URCA; 2CHU
de Reims, Reims, France; 3Department of Biochemistry and Food Chemistry, University of Turku,
Finland and 4Center for functional Nanostructures, Universita¨t Karlsruhe, Karlsruhe, Germany
Lumican is known to decrease melanoma progression in vivo and to retard cell migration in vitro.
The aim of the present study was to determine the active sequence of lumican core protein
involved in the inhibition of melanoma cell migration. We showed that the anti-migratory effect
of lumican on human melanoma A375 cells was mediated by its core protein. The glycosylated
form of lumican had no additional effects on melanoma cell migration, indicating that glycan
chains were not necessary for the inhibition. Using different recombinant and synthetic peptides
from lumican, we localized an active site in the LRR 9 domain of lumican core protein. We
propose the name lumcorin (fragment of lumican core protein) for the active peptide derived from
this site. Lumican and lumcorin affected the cell migration through a2 subunit containing
integrins. The siRNA directed against the a2 subunit abolished this effect on A375 melanoma
cells. Moreover, lumican inhibited the migration of Chinese hamster ovary (CHO) cells stably
transfected with a2 integrin subunit but not the wild type CHO cells. Lumcorin was able to inhibit
the migration of melanoma cells in vitro as well as the complete lumican core protein.
C16
Dermokine b and c: components of an extracellular matrix in the upper layers of
epidermis?
L Gazeilles, E Leclerc, E Toulza, G Serre, M Guerrin and N Jonca. UMR5165 UDEAR – CNRS/
UPS, Toulouse, France
The recently identified Dermokine gene (DMKN) undergoes complex alternative splicing leading
to the production of four kinds of isoforms among which b and g are secreted and specifically
expressed by granular keratinocytes. Hence, they could play an important role in late steps of
epidermal differentiation. In human inflammatory skin diseases, as well as during mouse skin
wound healing, DMKNb/g are strongly expressed by numerous cell layers of the hyperprolifera-
tive epidermis, and are concentrated at the apical poles of the cells. These results combined with
DMKN up-regulation after UVB irradiation of HaCat cells suggest a role in the barrier function.
Using yeast two-hybrid system, we identified an interaction between Galectin-3 (GAL3), an
ubiquitous and pleiotropic lectin, and the Glycine-Serine rich domain common to both DMKN
Immunohistochemical analysis showed a pericellular localization of GAL3 in the suprabasal
layers of human epidermis, consistent with interaction of the lectin with DMKNb/g. We
confirmed this interaction by GST pull-down and solid phase binding assay. DMKNb/g and GAL3
co-localization at the surface of corneocytes is currently analyzed. We also showed by
quantitative RT-PCR analysis that other secreted proteins, belonging to the extracellular matrix
family, are expressed in the suprabasal layers of human epidermis. They could form, together with
GAL3 and DMKNb/g, a protein scaffold in the granular and in the deepest cornified layers, thus
achieving a yet unexplored function in the upper layers of epidermis.
C17
Fetal cells persist in chronic wounds, form blood vessels and enhance healing
D Nassar, C Droitcourt, O Parant, E Mathieu-d’Argent, S Uzan, K Khosrotehrani and S Aractingi.
UPMC Univ Paris 6 and INSERM UMR-S938, CDR St-Antoine, Laboratoire des Cellules Souches
Fœtales, Paris, France
Background: Healing is a complex phenomenon that recruits cells from the marrow. Several
studies have demonstrated that fetal stem cells cells are transferred through pregnancy to the
maternal circulation and niche in the marrow. They persist decades after delivery and are able to
rescue maternal deficiencies. We asked here whether fetal cells transferred through pregnancy
may be found in maternal wound bed, and whether fetal cells of placental origin could intervene
in would healing. Materials and Methods: Wild type mice were mated with eGFP transgenic
mice. Surgical wounds were done on the back after delivery. Acute wounds were done on normal
skin. Chronic wounds were done on fibrotic skin secondary to local injections of bleomycin.
Single or double labelling used anti GFPþ , anti von Willebrand and anti CD45 antibodies. PCR
targeting the eGFP gene was realized. Evaluation of angiogenesis was done through morphometry
on slides labelled with anti CD31 and Lyve-1. Injections of placenta were done on acute wounds.
Results: At day 7, fetal cells were detected in 9/9 acute and chronic wounds. At day 18, fetal cells
were found in 10/11 chronic wounds but only 5/11 of acute wounds. At day 18, the level of GFP
cells was 185 versus 1.4 out of 104 maternal cells (Po0.01). In chronic wounds, fetal cells were
essentially CD45þ leukocytes at day 7, but were in contrast endothelial cells at day 18. Vessels
fully constituted of fetal GFP cells were found that appeared connected to maternal circulation.
Pregnancy did not modify angiogenesis and acute wound parameters while injection of placental
cells accelerated healing and increased lymphatic angiogenesis. Conclusion: Fetal progenitors are
mobilized to the wound where they participate to inflammation and angiogenesis. Although
transfer of cells through pregnancy did not influence the healing of normal wounds, injections of
higher number of placental cells was able to intervene in the healing phenomenon.
C18
A new germline FLNA mutation in a patient with Ehlers-Danlos syndrome and
periventricular nodular heterotopia
A-S Morin1, C Goizet2, C Prost3, A Blom3, L Laroche3, O Fain1 and F Caux3. 1Internal Medecine,
CHU Jean Verdier, 93140 Bondy; 2Genetics, CHU Pellegrin, 33000 Bordeaux and 3Reference
Center for Genetic Skin Diseases, CHU Avicenne, Bobigny, France
The FLNA gene, located on Xq28, encodes F-actin-binding cytoplasmic phosphoprotein filamin A
and is mutated in periventricular nodular heterotopia (PNH), a malformation of neuronal
migration characterized by nodules lining the ventricular walls. Patients with PNH and Ehlers-
Danlos syndrome (EDS) have recently been reported, some of them carrying FLNA mutations.
Here we report a woman with PNH, EDS and a novel FLNA mutation.
This woman presented with a history of seizures, PNH, pulmonary embolism and skin
hyperlaxity. Skin analysis by electron microscopy revealed no abnormality of size or morphology
of dermal collagen fibrils, neither flower-like cross section, nor dilated rough endoplasmic
reticulum in fibroblasts. The 47 coding exons of FLNA were analyzed by HRM or direct
sequencing on her DNA. A heterozygous deletion of 11 nucleotides associated with a 4
nucleotides insertion (c.4812-4822delinsCCAG) was identified in exon 29. The mutation results
in a frameshift and premature truncation of the protein (p.Thr1605GlnfsX6).
This novel FLNA mutation, located in the 14th Ig-like repeats (rod 1 domain), is clearly
deleterious and is expected to cause loss-of-function of filamin A. To date, only 2 missense and 4
truncation mutations have been reported in PNH combined with EDS. Such FLNA mutations may
cause EDS by impaired regulation of the cytoskeleton or by decreasing the cellular adhesion to
the matrix, resulting in loss of skin elasticity and strength of collagen.
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Biomechanical devices for skin extracellular matrix disorders: first approach with
a cutis laxa patient
R Debret1, C Pailler-Mattei2, G Boyer2, P Sommer1 and H Zahouani2. 1Institut de Biologie et de
Chimie des Prote´ines. UMR-CNRS 5086, France and 2Ecole Centrale de Lyon, Laboratoire de
Tribologie et Dynamique des Syste`mes. UMR-CNRS 5513, France
Extracellular matrix (ECM) components alteration is observed in many inherited and acquired
pathologies, and is also a consequence of normal aging. These defects within conjunctive tissues
have direct impacts on their functions and their mechanical behaviors. As the skin is the most
outer organ of the body, its mechanical parameters can be evaluated with non-invasive devices to
estimate dermal ECM integrity. In order to establish a pertinent relationship between extreme
ECM alterations and biomechanical parameters, our first experiments were conducted with a cutis
laxa patient. The cutis laxa syndrome is a rare disease characterized by a loose and inelastic skin
due to an incorrect elastogenesis. Using an original bio-tribometer, we characterized the cutis
laxa skin in vivo in a wide range of light contact forces, stress and strain. The indentation curves
obtained for the 17 years old cutis laxa patient were similar to those generally observed for a
healthy 80 years old person. We also analyzed the morphology of skin topography by laser
microscopy. Our results highlighted that besides ECM damages due to elastic fibers alterations in
cutis laxa, the epidermal surface is also modified with an increase of primary lines concomitantly
to a decrease of secondary lines when compared to healthy subjects. In conclusion, this
preliminary study demonstrates that development of skin mechanical parameters measurement
devices could be helpful for early diagnoses of ECM-related pathologies.
C20
Interactions of supramolecular networks from human skin basement membrane
zone
D-T Behrens1, D Villone1, M Koch2, L Bru¨ckner-Tuderman3, P Bru¨ckner1 and U Hansen1. 1Dept
Physiol. Chem. and Pathobiochem., University hospital of Mu¨nster; 2Center for Biochem. and
Dept Dermatol., Medical Faculty, University of Ko¨ln and 3Dept Dermatol., University Medical
Center Freiburg, Germany
The epidermidis and dermis of normal human skin are connected by a stable structural continuum
known as dermo-epidermal junction zone (DEJZ). Mutations in molecular components of the
DEJZ cause epidermolysis bullosa, a group of heritable blistering skin diseases. Therefore,
the characterisation of supramolecular interactions within the DEJZ is of importance. Here we
examined the interactions of laminin 332- and collagen IV-containing basement membrane
networks. Authentic suprastructures were isolated from extracts of human papillary dermis with
magnetic immunobeads either after perlecan removement or after digestion with heparinase III.
The materials were analyzed by immunogold electron microscopy, SDS-PAGE, and immuno-
blotting. The laminin 332-containing networks isolated after heparinase digestion seem to contain
no collagen IV, unlike networks isolated without digestion. Therefore, perlecan could serve as a
linker connecting the networks by its heparan sulfate chains. By digestion with heparinase this
connection is disrupted and the networks are separable. However, the collagen IV containing
networks seem to contain laminin 332 even after heparinase treatment. Furthermore, the laminin
332-containing networks show a clear labeling of perlecan core protein. Laminin 332-containing
networks as well as collagen IV-containing networks exhibit nidogen 1- and 2-labeling.
Therefore, our data suggest that nidogen 1 and 2 are not linkers but rather components of both
distinct networks.
C21
The murine skin pericyte—a multipotent stem cell participating in wound healing?
J Etich1, E Po¨schl3, S Eming2, D Belluoccio4 and B Brachvogel1. 1Institute for Biochemistry II;
2Institute for Dermatology, University of Cologne, Germany; 3University of East Anglia, United
Kingdom and 4Pacific Lab, Australia
Pericytes are mesenchymal cells closely associated to endothelial cells of the microvasculature.
Due to the lack of suitable purification techniques from mouse tissues little is known so far about
the role of vessel associated pericytes for skin physiology and pathology, even so a pivotal role for
this cell type in dermal wound healing was predicted several decades ago. It is speculated that
this cryptic cell type stabilise the microvascular network and also serve as a mesenchymal cell
reservoir for tissue repair. Recently, we have developed a new strategy to identify and isolate
murine pericytes that enables to study the functional relevance of pericytes in adult tissues. Using
an Anxa5-LacZ reporter gene expression system in a FACS sorting approach we could identify,
isolate and charcaterise perivascular mesenchymal stem cell-like cells (PVCs) from mouse
meninges. Here, we want to demonstrate that pericytes can also be identified and isolated from
the normal and wounded skin. Initial data show that Anxa5-LacZ reporter gene is expressed in the
microvasculature of skin as well as of various other tissues. By transcriptome profiling we have
identified novel cell surface markers for pericytes that can be used to identify pericytes in the
healthy and wounded skin. Using these novel cell surface markers we established a new cell
sorting strategy for purifying these pericytes from the skin. In future, these approaches will allow
us to analyse the contribution of pericytes to normal skin homeostasis and the restoration of skin
during wound repair.
C22
Myofibroblast proteolytic phenotypes in epithelial-stromal interactions:
differential modulation by TGFb and EMMPRIN
E Huet, B Valle´e, E-E Gabison and S Menashi. Laboratoire CRRET, CNRS EAC 7149, Universite´
Paris 12, Cre´teil, France
Extracellular matrix metalloproteinase inducer (EMMPRIN) is a cell surface glycoprotein enriched
on tumour cells and normal epithelia. It is mainly known for its ability to induce MMPs
production in fibroblasts following epithelial-stromal interactions during tumour invasion or
wound repair. A common feature in these processes is the activation of quiescent fibroblasts and
their differentiation into myofibroblasts, characterised by the expression of the alpha smooth
muscle actin (aSMA). TGFb is also implicated in epithelial-stromal interactions as it is secreted by
epithelial or tumour cells, promotes fibroblasts differentiation and regulates their MMPs
expression. This study was aimed at defining the relative roles of EMMPRIN and TGFb in
determining the phenotype of myofibroblasts, including their proteolytic, synthetic and
contractile properties, following epithelial-stromal interactions. Our results show that both TGFb
and EMMPRIN induce fibroblasts to acquire myofibroblasts like phenotype through the
upregulation of aSMA and the contraction of collagen lattices. However, while TGFb only
slightly increased MMP-2 but significantly decreased MMP-1, MMP-3 and urokinase, EMMPRIN
greatly increased the expression of these proteases. Taken together, our results suggest that the
relative level of EMMPRIN and TGFb may determine the phenotype of the activated fibroblasts
during tumour invasion or wound repair. Both induce the differentiation of fibroblasts but the
degradative or synthetic potential of these cells would depend on the temporal and spatial
balance of EMMPRIN and TGFb levels.
C23
Effects of transcriptional factors Sp1, Sp3, and NF-jB on the regulation of type I
collagen expression in normal and scleroderma human dermal fibroblasts
G Beauchef1, N Bigot1, M Kypriotou1, E Renard1, B Pore´e1, M Jolivet2, R Widom3, T Oddos4,
P Bordat4, M Demoor1, K Boumediene1 and P Gale´ra1. 1Laboratory of Extracellular Matrix and
Pathology, EA 3214, IFR 146 ICORE, Faculty of Medicine, University of Caen/Basse-Normandie,
CHU Caen; 2Department of Reconstructive Surgery, Saint-Martin Clinic, Caen; 3Arthritis Center,
Boston University School of Medicine, Boston, MA, USA and 4Johnson&Johnson Consumer
France, Campus de Maigremont, Val de Reui, Francel
Despite several investigations, the transcriptional mechanisms which regulate the expression of
both type I collagen genes (COL1A1 and COL1A2), in either physiological or pathological
situations, such as scleroderma, are not completely known. In this study, we have investigated the
roles of transcription factors Sp1 (Specific Protein-1), Sp3 and NF-kB (Nuclear Factor-kappaB) on
type I collagen expression by normal human (NHF) and scleroderma (SF) fibroblasts. Our results
show that the two zinc-finger proteins, Sp1 and Sp3, are strong activators of type I collagen
expression in NHF and SF. Moreover, they up-regulate COL1A1 gene transcriptional activity
through a region localized in the 112 bp proximal promoter in which we have identified the
functional cis-responsive elements. We also demonstrated that NF-kB, a master transcription
factor that plays a major role in immune response and apoptosis, down-regulates COL1A1 by a
transcriptional control and through the same region by which the zinc-finger mediate their effects.
Despite no existing consensus sequence for NF-kB in the COL1A1 proximal promoter, we find
that all the trans factors, including NF-kB, bind and/or are recruited on the COL1A1 promoter in
chromatin immunoprecipitation assays. Furthermore, Sp1/Sp3/hc-Krox (another zinc finger
protein) are necessary to mediate the inhibitory effect of NF-kB on COL1A1 in NHF and SF since
they are found to interact each others. As a conclusion, our findings highlight a new mechanism
for COL1A1 transcriptional regulation. Thus, this project would certainly allow to establish new
strategies targeting the treatment of fibrotic diseases.
C24
Genotype-phenotype correlation in inversa dystrophic epidermolysis bullosa
C Chiave´rini1, M Youssef1, A Charlesworth1,2, JF Cuny3, S Hadj Rabia4, G Meneguzzi2 and
JP Lacour1,2. 1Centre de re´fe´rence des e´pidermolyses bulleuses he´re´ditaires de Nice; 2INSERM
U634 UNSA; 3Hoˆpital Fournier Nancy and 4Hoˆpital Necker Enfants Malades Paris, France
The inverse form of recessive dystrophic epidermolysis bullosa (RDEB-I) is a rare form of inherited
dystrophic epidermolysis bullosa (DEB) characterized by mild cutaneous involvement that
improve with age and severe lesions of mucosas. RDEB-I has been associated with genetic
mutations in the COL7A1 gene, but the molecular mechanisms underlying the predominantly
fragility of the mucosa remain obscure. In this work, we report six new cases of RDEB-I and
describe their clinical and histological features. Genotyping of these patients has identified 6
novel mutations in the COL7A1 gene and correlates the clinical manifestations of the condition to
the occurrence of glycine/arginine substitution in the distal part of collagenous domain (TCH) of
collagen type VII (Col7). THC is composed of repeating -Gly-X-Y- sequences that fold into a triple
helix which contains 19 interruptions. Interestingly, in RDEB-I the four causative glycine
substitutions fall close to these interruptions and the two arginine substitutions involve two highly
conserved stretches of amino acids judged to be crucial for the function of collagen VII and to
mediate interactions with another collagen VII molecule. Then glycine substitutions could
destabilize the triple-helix and arginine substitutions could induce a modification of the
intermolecular interactions of col7 or modify its tertiary or quaternary structure which render col7
less stable against proteolysis and cause abnormal folding of the molecule. Finally, the peculiar





Towards a new skin subsitute: in vitro and in vivo characterization of its
biodegradability and its tissue integration
H Dabboue, O Guillaume, X Garric and J-P Mole`s. UMR5247, Montpellier, France
Progresses in tissue engineering and biomaterials allow us to design a new dermal substitute that
would temporarily replace the tissue loss and that would stimulate its own colonization from
surrounding healthy tissue as soon as its hydrolytically degrades. This concept of temporarily
medical devices is already used with success for orthopedic screws. Our approach consists in
using bioresorbable polymers (poly(a-hydroxy-acid)s derived from lactic acid (PLA50-PEO-PLA50)
to develop dermal substitutes. We investigate whether these scaffolds are degraded in chronic
wound conditions, are colonized by dermal cells in vitro and in vivo by surrounding tissues.
Chronic wounds fluids did not affect the degradation rate of the polymer. We observed a drastic
decrease in molecular masses after g-rays irradiation doses. During in vitro cytocompatibility and
the formation of a dermal equivalent, data showed that fibroblasts proliferated and migrated
within copolymer scaffold, and specific extracellular matrix proteins (collagens, fibronectin,
elastin) were secreted and deposited onto the surface of the scaffold. Finally, after the
implantation of polymer scaffold for a period of 3 months in the inguinal fold of mice, we
observed a great colonization of surrounding tissues accompanied by the formation of an arterio-
venous network and significant polymer degradation. These studies demonstrate the adequation
of the PLA50-PEO-PLA50 dermal substitutes with tissue integration and healing time since
neovascularisation occurred shortly after grafting.
C26
Molecular mechanisms of hypopigmentation in infantile cystinosis
C Chiaverini, M Djedaini, E Flori and R Ballotti. INSERM U 597, Faculte´ de me´decine, Nice,
France
Cystinosis is a lysosomal transport disorder characterized by an intra-lysosomal accumulation of
cystine and Fanconi’s syndrome leading to end-stage renal disease. The causative gene CTNS
encodes for the lysosomal protein cystinosin that acts as a cystine/Hþ -symporter. Most of
patients with cystinosis have congenital hypopigmentation suggesting that cystinosin is involved
in melanogenesis. The aim of this study was to determinate the role of cystinosin in
melanogenesis using murine B16 melanoma cells. First, using a CTNS-GFP construct, we
showed by immunofluorescence (IF) and biochemistry studies that CTNS is a melanosomal
protein. Then, we showed that Ctns silencing (siCTNS) inhibited AMPc induced cell pigmentation
and reduced melanin synthesis by more than 50% compared to control cells. This effect was due
to a dramatic decrease in tyrosinase protein expression. Interestingly Ctns silencing induces an
increase of tyrosinase messengers’ expression suggesting tyrosinase degradation. We showed that
proteasome inhibition did not prevent the decrease in tyrosinase expression evoked by CTNS
specific siRNA but the inhibition of lysosomal proteases prevented the degradation of tyrosinase
but did not induce pigmentation. Since CTNS is a cystine/Hþ co-transporter we studied the
melanosomal pH. Indeed, we showed by IF that Ctns silencing inhibit the AMPc basification of
melanosomes. Finally we have shown that chemical basification of melanosomes prevented the
decrease in tyrosinase expression and restored the pigmentation. These data suggest that
cystinosin is involved in AMPc induced basification of melanosome that allow the correct
addressing of tyrosinase in melanosome and then melanogenesis and raise new hypothesis for
kidney involvement.
C27
Genetic evaluation of a familial mastocytosis
A-C Bursztejn1,2, M Bronner2, G Kanny3, A Barbaud2, M Morisset3 and P Jonveaux2.
1Dermatology department, CHU Nancy; 2Genetic department, CHU Nancy and 3Immunlogy
and allergology department, CHU Nancy, France
Introduction: Mastocytosis includes different diseases: cutaneous, systemic mastocytosis, sporadic
or familial mastocytosis (FM). The most frequent type is cutaneous mastocytosis in children; the
less frequent type is FM. Whereas sporadic mastocytosis have been clearly associated with a
somatic mutation of c-kit gene, only few FM were associated with germline mutations of this
gene. In this study, we searched for a germline mutation in a 3 generations FM. Patients and
Methods: A family with 5 affected members in three generations was evaluated for c-kit germline
mutation. All patients, except one, presented cutaneous mastocytosis developed in early
childhood. Only one of them presented systemic mastocytosis after her first pregnancy. Genetic
studies were performed on genomic DNA extracted after informed consent from peripheral blood
mononuclear cells. DNA sequencing of the 21 exons of c-kit gene and exon-intron boundaries
was performed using 21 sets of primers. Results: We chose to sequence c-kit first in one of the
affected members. No variant has yet been identified within the coding exons. Only one
polymorphism (already described) was noted in intron 18. Discussion: The recurrent mutation
(D816V) identified in sporadic mastocytosis is generally not associated with FM. Few mutations in
coding exons (8, 9, 10 and 11) have been identified in FM, however, most of the cases were not
associated with such mutations. To date, we could not identify a germline mutation in c-kit
coding exons for the family evaluated here. Linkage analysis should be performed to verify that
chromosome 4 is indeed involved in this family. If this is the case, c-kit introns, regulating regions,
promoter or 30UTR should be thereafter evaluated.
C28
c-Kit mutants require hypoxia-inducible factor 1a to transform melanocytes
G Monsel1, N Ortonne1,2, M Bagot1,3, A Bensussan1,3 and N Dumaz1. 1INSERM U976, Hoˆpital
Saint Louis, Paris, France; 2Department of Pathology, and 3Department of Dermatology, AP-HP,
Groupe Hospitalier Henri Mondor-Albert Chenevier, Cre´teil, France
Although many studies have highlighted the critical role of c-Kit in normal melanocyte
development, its role in melanoma development remains unclear. Whereas c-Kit expression is
often lost during melanoma progression, a subset of melanoma has been found to overexpress
c-Kit and mutations activating c-Kit have recently been identified in some acral and mucosal
melanoma. To address the role of these c-Kit mutants in the transformation of melanocytes, we
characterized the physiological responses of melanocytes expressing the most frequent c-Kit
mutants found in melanoma (K642E and L576P) and a novel mutant we identified in an acral
melanoma. We analyzed signaling pathways activated downstream of c-Kit and showed that all
three mutants led to strong activation of the PI3K pathway but only weak activation of the Ras/Raf/
Mek/Erk pathway, which was not sufficient to promote uncontrolled melanocyte proliferation and
transformation. However, these mutants cooperated with a constitutively active form of Hypoxia-
Inducible Factor 1a (HIF1a) to activate the Ras/Raf/Mek/Erk pathway and transform melanocytes.
Proliferation of melanocytes transformed by mutant c-Kit was specifically inhibited by imatinib.
These results demonstrate for the first time that melanocytes require a specific epigenetic
environment to be transformed by c-Kit mutants and highlight a distinct molecular mechanism of
melanocyte transformation.
C29
Detection of alpha- and beta-human papillomavirus (HPV) in cutaneous
melanoma: a matched- and controlled study using specific multiplex PCR
combined with DNA microarray primer extension
J-B Ruer1, T Gheit2, L Pe´pin1, C Vidal3, M Tommasino2, J-L Pre´tet1, C Mougin1 and F Aubin1.
1Universite´ de Franche-Comte´, EA3181, IFR133, Besanc¸on; 2IARC, Lyon and 3Centre
d’Investigations Cliniques, CHU de Besanc¸on, France
There are few contradictory studies investigating the involvement of HPV in melanoma. We
designed a controlled study to evaluate the HPV DNA prevalence in melanoma.100 patients with
cutaneous malignant melanoma diagnosed between 2002 and 2006 were included. Comple-
mentary wide excision (healthy skin) was performed in 85 patients and was used as internal
control. After DNA extraction, 68 different HPV types were studied using a multiplex PCR
combined with microarray primer extension. We did not observe any statistical significant
difference in terms of HPV DNA prevalence in melanoma (38.8%) and in healthy skin (HS) from
wide excision (42.4%). 21 different HPV types were detected but only one type was present in the
majority of our samples (80/85 melanoma vs 59/66 HS). The distribution of HPV genera and types
was similar in melanoma and HS, and beta-HPV was predominant (30.6% and 31.8%). Among
alpha-HPV, HPV16 was predominant. No correlation between clinical and pathological
melanoma characteristics and HPV DNA prevalence was found. Our data do not support a
role of HPV infection in melanocarcinogenesis, but confirm previous data suggesting that HPV
DNA is widely distributed among the population and that occult HPV infections are frequent.
Furthermore, specific HPV types, such as alpha-HPV16 and beta-HPV species 2 may be involved
in a sub-group of melanoma.
C30
Gene expression profiles of human melanoma cells with different invasive
potential reveal TSPAN 8 as a novel mediator of invasion
M El Kharbili1, J Lamartine1, A de la Fouchardie`re2, F Le Naour 3 and O Berthier-Vergnes1.
1Centre de Ge´ne´tique Mole´culaire et Cellulaire, UMR-CNRS 5534, Universite´ C. Bernard Lyon 1;
2De´partement d’Anatomie et Cytologie Pathologiques,d’Anatomopathologie, Centre Le´on Be´rard,
Lyon and 3INSERM U602, Universite´ Paris-XI, Villejuif, France
The events occurring during the penetration of melanoma cells through the dermal-epidermal
junction, which is the earliest step in the process of metastasis, remain ill defined. Previously, we
successfully selected a pair of isogenic melanoma clones from the same parental cell line that
differ in their ability to invade dermis in human skin reconstructs. To gain insight into the
mechanisms of dermal invasion and in search of early prognostic markers, we compared the gene
expression profiles of the two clones. Among the 26,496 genes analyzed by cDNA microarrays,
only 24 genes were found to be upregulated (43-fold; Po0.001) in invasive cells. One of the
most abundantly expressed genes in invasive cells is TSPAN8, not yet described in cutaneous
melanoma, which encodes tetraspanin 8 belonging to the tetraspanin family. Subsequent analysis
of melanoma cell lines confirmed that TSPAN8 is exclusively expressed by invasive cells, but not
by normal melanocytes, as assessed by real time RT-PCR, flow cytometry and western blot
analysis. Consistent with the in vitro findings, an immunohistochemical study on paraffin-
embedded melanocytic lesions revealed that TSPAN8 is expressed in primary tumors, in lymph
node metastasis but not in normal skin. More importantly, knockdown of TSPAN8 by RNA
interference reduced the invasive outgrowth of melanoma tumor spheroids embedded in
matrigel. By contrast, TSPAN8 silencing did not alter cell viability and cell proliferation.
Collectively, our data implicate TSPAN8 in the acquisition of an invasive behavior of melanoma
cells. Whether TSPAN8 may serve as a novel target for early detection and treatment of
melanoma remains to be defined.
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Plasma proteasome level is a reliable marker for nodal and distant metastases in
melanoma
P-E Stoebner1,3, L Henry2 , T Douche3, S Uttenweiler-Joseph4, P Henri3, T Lavabre-Bertrand2,
B Monsarrat4, J Martinez3 and L Meunier1,3. 1De´partement de Dermatologie, CHU Nıˆmes and
2Laboratoire de Cytologie Clinique et Cytoge´ne´tique, CHU Nıˆmes. 3Institut des Biomole´cules
Max Mousseron, UMR CNRS 5247, Montpellier. and 4Institut de Pharmacologie et de Biologie
Structurale, UMR CNRS 5089, Toulouse, France
Proteasomes are the main non-lysosomal proteolytic structures which regulate crucial cellular
processes. Circulating proteasome (proteasome-c) levels can be measured using an ELISA test and
can be considered as a tumor marker in several types of malignancy. We measured proteasome-c
levels in 101 melanoma and 72 controls. Melanoma patients were sub-classified in stage I/II
(n¼ 44), stage III (n¼ 33) and stage IV (n¼ 24) according to the AJCC staging system for
cutaneous melanoma. In order to determine the proteasome-c subunit composition we performed
a proteomic analysis of immunopurified proteasome-c in stage IV melanoma (n¼ 3). Proteasome-
c levels were significantly higher in patients with stage IV and stage III with lymph node
metastasis (n¼14) (8,864±1,272 ng/ml and 5,007±428 respectively) compared to controls
(2,534±187 ng/ml; Po0.001) to stage I/II (2,804±159 ng/ml; Po0.001) and to stage III after
curative regional lymph node resection (2,812±277 ng/ml; Po0.001). With a cut-off of 4,300 ng/
ml, diagnostic specificity for regional or distant metastatic evolution was 97% with a sensitivity of
68%. Proteomic analysis showed that all 20S proteasome and immunoproteasome subunits were
present in the plasma. Proteasome-c is a reliable marker for metastatic dissemination in
melanoma patients.
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Dual anticancer effects of the alkaloid Lamellarin-D in melanoma cells
C Ballot1, J Kluza1, A Martoriati1, S Buche 1,2, P Formstecher1, P Marchetti1 and L Mortier1,2.
1JP Aubert research centre, INSERM U837, place de Verdun, Lille (FRANCE) and 2Clinique de
Dermatologie, Hoˆpital Huriez, Lille, France
The marine alkaloid Lamellarine D (LamD) shows interesting anticancer properties against a large
panel of cancer cell lines, notably on melanoma cells. Initially identified as a potent nuclear
topoisomerase-1 poison, LamD can directly permeabilize cancer cells mitochondria. In this
study, the antitumor effects of LamD were examined in vitro and in vivo using the human
melanoma cell line, HBL. At doses in the micromolar range, LamD induced full-blown apoptosis
of HBL characterized by a rapid mitochondrial dysfunction (drop in mitochondrial membrane
potential, inhibition of the mitochondrial respiration and generation of mitochondrial ROS)
followed by the activation of caspases culminating in nuclear apoptosis. Conversely, HBL Rho0
cells, devoid of mitochondrial DNA, were totally resistant to LamD-mediated apoptosis
suggesting that functional mitochondria are required for Lam D cytotoxicity. At lower doses
(nanomolar range), LamD was unable to kill HBL cells. However, upon Lam D exposure, we have
observed in HBL cells, the apparition of early DNA damages, irreversible cell cycle arrest in G2-
M phase and activation of the P53-P21 dependent pathway. Furthermore, LamD-treated cells
displayed some morphological and biochemical (SA-b Galactosidase activity) changes consistent
with the development of a senescence-like phenotype in vitro as well as in vivo in a murine
xenograft model of melanoma. This senescence phenotype was associated with the generation of
extra-mitochondrial NADPH dependent ROS production. In conclusion, LamD acts as a
promising anti melanoma drug displaying both senescence and apoptosis depending on its
concentration.
C33
Cyclic AMP inhibits vasculogenic mimicry through multiple signaling pathways in
agressive human melanoma cells
J-C Lissitzky, D Lombardo and P Verrando. INSERM UMR 911–University of Mediterranea,
School of Medicine Timone, Marseille, France
Genomic approaches have revealed clinically unrecognized sub-classes of melanoma tumors
underscoring an heterogeneity of their cell populations. In this regard, aggressive melanoma cells
(AMC), but not their poorly aggressive (isogenic) counterparts, can acquire a plastic, multipotent,
stem cell-like phenotype and engage in a process termed vasculogenic mimicry (VM). It coincides
with a poor clinical outcome. Our experiments reveal that in AMC, an increase in cyclic AMP by
forskolin or G protein-coupled receptor ligands (GPCR-L) in vitro inhibited VM to different
extents. Pharmacologic modulators showed that, unlike the protein kinase A (PKA), the Exchange
protein directly activated by cyclic AMP (Epac) contributed to VM inhibition. Ras-associated
protein-1 (Rap1) activation assays revealed that cyclic AMP-elevating agents induce a PKA-
independent activation of Epac/Rap1. Forskolin PKA-independently inhibited extracellular signal-
regulated kinase 1/2 (ERK1/2), a mediator of VM, contrary to either Epac/Rap1 signaling, PKA
modulation or GPCR-L. Furthermore, and unlike to activated Epac and GPCR-L, the forskolin also
inhibited phosphatidyl inositol-3-kinase (PI3K)-mediated activation of protein kinase Akt that is
required to promote VM. These data show that GPCR-L and forskolin inhibit VM through a PKA-
independent but Epac/Rap1 dependent signal. In addition, the forskolin blocks the PI3K/Akt
module and inactivates, in a PKA- and an Epac-independent manner, ERK1/2 activity that is
necessary to promote VM. Thus cyclic AMP inhibits VM through multiple signaling pathways, a
result that may be helpful to identify new targets for therapeutic intervention.
C34
Mannose-6-phosphate: a new class of anti-angiogenic compound with potent anti-
tumoral activity
J-P Mole`s1, V Barragan-Montero1, P de Santa Barbara2, B Jover3 and J-L Montero1. 1UMR5247,
Montpellier; 2Inserm ERI25 Montpellier, and 3EA3127, Montpellier, France
Mannose-6-phosphate (M6P) and its derivatives have been proposed to prevent cheloid scar
formation through a mechanism involving TGF-b but the cells targeted by this treatment are still
unknown. After testing with no success the influence of M6P and its derivatives on keratinocyte
and fibroblast proliferation, we hypothesized that angiogenesis could be affected by M6P. Thus,
8 derivatives of the M6P were synthesized including 3 on a large scale. Some of them were
bioisosteres, some were not. In vitro angiogenic tests (aorta ring cultures and chick
chorioallantoic membrane assays) gave us the opportunity to test 6 derivatives. We found that
among this series, some compounds could be activators and others inhibitors of angiogenesis at
the micromolar concentration. In a B16 melanoma in vivo assay, mice were injected
subcutaneously with 500,000 B16 cells and treated with 300 mg/kg with different compounds.
M6P showed 65% inhibition of tumor growth and 80% survival rate at day 20. The azido
derivative was also an inhibitor but less efficient (40%). Inhibition of angiogenesis has proven to
be a valuable approach to treat numerous tumor types and new compounds for anti-angiogenesis
need to be discovered in order to circumvent side effects of the current inhibitors. The M6P




T-plastin in Cutaneous T Cell Lymphoma: involvement of NFAT activation
E Be´gue´1, F Jean-Louis1, H Bachelez1, G Courtois2 and L Michel1. 1INSERM UMRS 976. Centre
de Recherche sur la Peau. Hoˆpital Saint-Louis. Paris and 2INSERM U781. Hoˆpital Necker. Paris,
France
Primary cutaneous T cell lymphomas (CTCLs) are a heterogeneous group of non-Hodgkin extra-
nodal T cell lymphomas, from which mycosis fungoides (MF) and Se´zary syndrome (SS) are the
two major clinical variants. In the past few years, transcriptome analysis, allowed the
identification of T-plastin as an upregulated gene in CTCL cells from SS patients, while this
latter plastin isoform is not expressed by normal T lymphocytes (Kari et al. J Exp Med 2003; van
Doorn et al. Cancer Res 2004; Nebozhyn et al. Blood 2006). In the present study, we studied T-
plastin expression in a large cohort of CTCL patients, compared with a wide range of T-cell
lymphoproliferative disorders, and searched for involved transcriptional factors.
Peripheral blood lymphocytes (PBL) were isolated from circulating blood of patients with CTCL
(n¼ 36), MF (n¼12), unidentified erythroderma (n¼10), hypereosinophilic syndrome (n¼8),
other lymphoproliferative disorders (n¼ 10) and healthy donors (n¼ 56). The expression levels of
T-plastin and L-plastin was quantified by quantitative real-time polymerase chain reaction assay
and CTCL cell lines (SeAx, MyLa) as well as in control leukemic Jurkat cells. Our results show that
T-plastin mRNA were detected in 80% of SS patients, while no expression was detectable in
patients with MF (n¼ 12), idiopathic erythroderma (n¼ 10), hypereosinophilic syndrome with
clonal T-cell subset (n¼8), and healthy donors. Although Hut-78 cell line does constitutively
express T-plastin, SeAx cells and MyLa (derived from one SS and one MF patient), respectively, do
express T-plastin only after stimulation with PMAþ ionomycin (Io). Stimulation of T-plastin
negative-SS patients by PMAþ Io induced its transcription in 4/5 patients and, of interest,
stimulation of control PBLs also induced T-plastin transcription, although at low levels.
Cyclosporin inhibited by 50% constitutive or PMAþ Io-induced transcription of T-plastin. By
EMSA and gene reporter assay, we demonstrated that activation of nuclear factor of activated T
cells (NFAT) was responsible, at least partially, for T-plastin expression in tumor T cells.
Altogether, our results suggest that T-plastin expression is restricted to Se´zary syndrome and might
be considered as a molecular marker, in association with others such as KIR3DL2, in diagnostic
procedures.
P2
TCR c gene rearrangement in cutaneous T-cell lymphoma: comparative study of
PCR with denaturing gradient gel electrophoresis and GeneScan analysis
A-L Goeldel1,3, P Cornillet-Lefebvre2, A Durlach3, P Birembaut3, P Bernard1, P Nguyen2 and
F Grange1. 1Department of Dermatology, Hoˆpital Robert Debre´, Reims, France; 2Laboratory of
Haematology, Hoˆpital Robert Debre´, Reims, France and 3Laboratory of Histopathology, Hoˆpital
Maison Blanche, Reims, France
The usefulness of T-cell receptor gene rearrangement (TCR-GR) analyses for differentiating
cutaneous T-cell lymphoma (CTCL) from benign inflammatory disorders (BID) has been
insufficiently studied to date. Our objective was to evaluate the diagnostic value of TCR-GR
analyses, comparing polymerase chain reaction (PCR) with denaturing gradient gel electrophor-
esis analysis (DGGE) and BIOMED-2 standardized protocol PCR with GeneScan analysis
(BIOMED-2-GS). Both were performed in 157 patients evaluated for initial features suggestive of
CTCL between 1996–2007. After clinical and histological review, the final diagnosis was CTCL in
77 cases, and BID in 80 cases. DGGE and BIOMED-2-GS had a similar diagnostic value for
distinguishing CTCL from BID, with a sensitivity of 74 and 76.6%, respectively, and a specificity
of 86.2%. Positivity rates did not depend on the PCR method but varied according to the type of
CTCL (73–75% in mycosis fungoides, 90–100% in Se´zary syndrome, 40–60% in lymphomatoid
papulosis and 100% in other types). The observed concordance between both methods was 90%
and the kappa coefficient was 0.79. We conclude that BIOMED-2-GS analysis of the TCRg gene is
as sensitive and specific as DGGE for CTCL diagnosis. In addition, BIOMED-2-GS is less time-
consuming and gives more information concerning the size and nature of TCR-GR.
P3
Immunohistochemical analysis of bexarotene-exposed cutaneous skin explants
and skin biopsy specimens from patients with CTCL before and after treatment
with Targretin
A-C Knol1, J-M Nguyen3, A Khammari1,2, G Que´reux1,2, A Brocard2, F Ballanger2 and B Dre´no1,2.
1INSERM, U892, Nantes; 2Clinique dermatologique, CHU de Nantes and 3PIMESP, Nantes,
France
There are few approved therapies for cutaneous T-cell lymphoma (CTCL). In any case, biologic
modifiers seem of more interest than chemotherapy. The two most important are interferon alpha
and retinoids and among them, bexarotene has recently been introduced. Concerning its
mechanism of action, bexarotene is thought to act not only on the malignant T-cells but also on
keratinocytes and other skin cells and has been demonstrated to induce CTCL cell-lines and
patients peripheral blood lymphocytes apoptosis. However, nothing is known about its mode of
action on keratinocytes and Langerhans cells. The aim of this work was to determine the
modalities of bexarotene action on keratinocytes and Langerhans cells. Immunohistochemical
analysis of Langerhans cells (CD1a), activation marker (HLA-DR), adhesion molecule (ICAM-1)
and apoptosis-related markers (CD95, CD40) was conducted on frozen sections of bexarotene
exposed (for 24 and 48 hours) cutaneous explants and skin biopsy specimens from patients treated
with bexarotene for 6 months. None of the studied marker was significantly modulated both on
cutaneous explants and on skin biopsy specimens from patients after treatment with bexarotene,
compared to controls. Bexarotene therapy does not act on Langerhans cells frequency or on
keratinocytes features evaluated in this study. Bexarotene’s target would thus remain T-cells by
inducing their apoptosis. This work was supported by grants from Cephalon laboratories.
P4
Detection of epigenetic modifications in (normal) lymphocytes and lymphocyte-
derived (leukemic) cell lines by Raman microspectroscopy
M Poplineau1, A Trussardi-Re´gnier1, D Vallerand2, M Manfait1, P Bernard2, F Antonicelli2 and
O Piot1. 1CNRS UMR 6237, Reims, France and 2Service de Dermatologie, CHU, Reims, France
Histone deacetylases (HDACs) play an important role in the epigenetic regulation by catalyzing
the removal of acetyl group on histones, which leads to chromatin condensation and promotes
transcriptional repression. Aberrant epigenetic changes are involved in many diseases such as
cancer or immune pathology, highlighting HDACs as pharmacological target. We then focused
our attention on the detection of epigenetic structural changes by Raman microspectroscopy, a
non destructive method which permits to probe the biochemical composition (lipid, sugar,
protein, nucleic acids) of biological samples such as living cells. Our objective of our study has
been to follow the effects of two different HDACs inhibitors (TSA, MS-275) on normal
lymphocytes and lymphoblastic leukemia cells (Jurkat) by the Raman spectral signature.
Detection of histone acetylation by AUT page from human lymphocytes and Jurkat cells revealed
an increase in histone H4 acetylation following TSA or MS-275 treatment. Raman analyses were
performed directly on living cells, without any staining or cell fixation. Compared to spectra of
untreated cells, spectra of TSA- or MS-275 -treated cell showed clear, reproducible changes of
specific Raman vibrations assigned to protein, sugar or lipid. Statistical analyses of the Raman
data revealed a relationship between the HDACs inhibitors-induced biological signature and
the spectral signature in Jurkat. Thus, we showed in this study the potential of Raman
microspectroscopy to reveal epigenetic modifications in lymphocyte cells.
P5
Implication of oxidative stress in contact allergy
C Migdal1, L Foggia1, A Ferrer1, M Tailhardat2, P Courtellemont2, M Haftek1 and M Serres1. 1EA
41-69, Universite´ Claude Bernard Lyon 1 (UCBL1), Pavillon R, Hoˆpital E. Herriot, Lyon, France
and 2LVMH Recherche, Saint Jean de Braye, France
The maturation of dendritic cells (DCs) induced by contact allergens is characterized by an up-
regulation of several markers (CD54, CD80, CD83, CD86, CMH-II) and cytokine production (IL-
8, TNF-a). The aim of this study is to determine the role of oxidative stress in DC maturation and
to better understand the intracellular events involved in such process. DCs derived from
monocytes (mono-DCs) were used but as they could display inter-donors variability, several
sensitizers (such as DNCB, nickel, MCI/MI, cinnamaldehyde, citral, mercury compounds, etcy)
versus an irritant (SDS) were also tested on a human monocytic cell line (U937). These cells
respond also to chemicals but not irritant by up-regulating CD86 expression and IL-8 secretion.
This activation was inhibited in presence of thiol antioxidants. Indeed, all sensitizers and mercury
compounds are able to induce a direct ROS production associated with a change in mito-
chondrial potential assessed using fluorescent probes. This oxidative stress led to an increase of
cell apoptosis (annexin V staining and caspase activation). Moreover, DNCB and thimerosal, a
mercury compound, induced glutathione depletion. In addition, MAPKs pathways (p38 MAPK,
Erk1/2) and intracellular calcium concentration was altered in response to sensitizers (activation
or inhibition of kinases, enhanced concentration of Cai
2þ ). These data display arguments that
monocytic cell line will be useful to study the effect of sensitizers as they respond similarly to
mono-DCs and thus to support the hypothesis that oxidative stress play a major role in early
events in DC maturation.
P6
Usefulness of commercial ELISA kits for the detection of anti-BP180 and BP230
autoantibodies in patients with bullous pemphigoid (BP): a retrospective study
J Charneux1, J Lorin2, C Barbe3, F Vitry3, F Antonicelli2 and P Bernard1. 1Service de
Dermatologie; 2Centre de Re´fe´rence Maladies Bulleuses Auto-immunes et and 3CRICAM, CHU
de Reims, Reims, France
Contrary to BP180/NC16a domain autoantibodies detection which has been extensively studied,
very little is known about the usefulness of BP230 autoantibodies using commercial ELISA in
patients with BP. In this retrospective study, we assessed the diagnostic value of a commercial
BP230 ELISA (MBLs) in conjunction with the BP180/NC16a ELISA (MBLs) currently used in
routine practice in patients with BP. A total of 138 patients (mean age: 79 years) with BP seen at
our department between 1998 and 2007 were included in the study, for whom a serum was
available at the time of diagnosis. Clinical and immunopathological data were collected from the
patients’ files using a standardized questionnaire. By this BP230 ELISA, 81/138 (59%) BP sera
were found positive (ie titer X9 UI/ml) at the time of diagnosis, whereas 117/136 (86%) patients
were positive using BP180/NC16a ELISA. From these 138 BP patients, 73 sera (53%) were positive
with both BP230 and BP180 ELISAs, 44 (32%) with BP180 ELISA only, 8(6%) with BP230 ELISA
only and 12 (9%) were negative with both ELISAs. Anti-basement zone antibodies titers as
detected by IIF were found higher in sera with positive (median: 1/800) than in those with
negative BP230 ELISA (median: 1/200). At the time of diagnosis, BP230 ELISA was not more
frequently positive in patients with extensive BP (410 daily blisters) compared with those with
limited disease (57 vs 43%; P¼ 0.14) and BP230 ELISA titers were not correlated to the number of
daily blisters (P¼ 0.51). In contrast, BP ELISA titers correlated well with disease activity (ie
number of daily blisters) at the time of diagnosis (Po0.0001). Our present data demonstrate that
combining BP230 ELISA and BP180 ELISA is useful for the diagnosis of BP, but that BP230 ELISA
is less sensitive and less correlated to disease activity than BP180 ELISA.
2530 Journal of Investigative Dermatology (2009), Volume 129
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Comparison between standard ELISA and sandwich-ELISA for serodiagnosis of
human anti-laminin-5 autoantibodies
G Bourgeois1, J Lorin1, F Antonicelli1, P Rousselle2, T Tabary3 and P Bernard1. 1Laboratoire de
Dermatologie et Centre de Re´fe´rence ‘‘Maladies Bulleuses Auto-immunes’’, CHU de Reims;
2IBCP CNRS, Lyon et and 3Laboratoire d’immunologie, CHU de Reims, Reims, France
Mucous membrane pemphigoid (MMP) is an autoimmune disease with auto-antibodies directed
against different components of the basement membrane such as BP180, a6b4 and especially
laminin-5 (Lam-332). In this study, we investigated whether Lam-332 presentation/orientation
could improve the detection sensitivity/specificity of anti-lam-332 antibodies by ELISA
techniques. ELISAs have been performed using lam-332 purified by affinity chromatography,
rabbit polyclonal antibody (L132), mouse monoclonal antibodies specific to each Lam-332 chains
(BM165: anti-a3, D4B5: anti-b3, 6F12: anti-g2) and sera from patients with MMP and without any
auto-immune diseases. In direct ELISA Lam-332 coating was at 0.3mg diluted with PBS on
Maxisorbs plates. In these conditions, the OD ratio of coated versus control (no coating) was 20.
Presentation of Lam-332 (sandwich–ELISA) by capture antibodies against the different chains
displayed lower OD ratios (from 4 to 7.2), demonstrating that direct ELISA had the best sensitivity.
The direct ELISA method was then validated by analysis of human sera from MMP and ‘‘healthy’’
patients which showed OD values over 1.3 (ratios from 7 to 17) and below 0.25, respectively.
Even though sandwich-ELISA has less sensitivity than direct ELISA, this technique could be useful
in the future to detect specific subclass antibodies towards a, b and g Lam-332 chains.
P8
Citrullination and petidylarginine deiminases during wound healing in mice
F Coudane1, M-C Me´chin1, A Huchenq1, V Adoue1, R Nachat1, C Caubet1, G Serre1 and
M Simon1. 1UMR5165, CNRS-University of Toulouse III, Toulouse, France and 2Boehringer
Ingelheim Pharm., Inc., Ridgefield, CT, USA
Deimination or citrullination is a posttranslational modification catalyzed by peptidylarginine
deiminases (PADs) that convert protein-bound arginines into citrullines. PAD1-3 are differentially
expressed in the epidermis, and deimination of filaggrin and keratins plays a pivotal role in the
cutaneous barrier functions. A decrease of deiminated K1 has been observed in psoriasis, a
disease with features of a chronic wound response. Moreover deimination has been observed in
various inflammatory conditions. To investigate deimination in wound healing, we evaluated the
presence of citrullinated proteins and the expression of Pad3 during cutaneous wound closure.
We performed 4 mm diameter full-thickness punches on adult mouse back skin, and analyzed the
wound recovery during 10 days by immunohistology and western blotting of excised wounds.
Citrullinated proteins were detected in the non-injured epidermis, mainly in the stratum corneum,
but also in the fibrin clot where deiminated protein could correspond to (fibrin) ogen. Pad3,
normally stained in the stratum granulosum, was not detected in the hyperproliferative tongue but
shown to be coexpressed with (pro) filaggrin in a large number of cell layers in the neoepidermis.
Moreover, wound-healing and citrullination in the fibrin clot seemed to be Pad2-independent, as
shown using Padi2/ mice. These results suggest a possible implication of Pad3 in the barrier
restoration.
P9
Lysyl oxidase silencing impairs keratinocyte terminal differentiation
G Le Provost1, R Debret1, V Cenizo2, B Kaniewski1, G Aimond1, V Andre´2 and P Sommer1.
1Institut de Biologie et de Chimie des Prote´ines. Lyon, France and 2BASF Beauty Care Solutions,
Lyon, France
Lysyl Oxidase (LOX) is an extracellular enzyme that catalyzes cross-linking of fibrillar collagens
and elastin in connective tissues. Beyond its role in the extracellular matrix, LOX has also been
reported to influence cell behavior, like chemotactical responses, proliferation and switch
between normal and malignant phenotypes. Depending on the considered tissue and cell type,
LOX functions remain unclear. We previously described that LOX was expressed in suprabasal
keratinocytes of human normal epidermis. In order to understand its role in epidermis, we used
the immortalized keratinocyte cell line N/TERT-1 to modulate LOX expression. Stable
transduction of a vector expressing a short hairpin RNA was assessed by lentiviral-based strategy.
In N/TERT-1 monolayer cultures, LOX silencing delayed apparition of early differentiation
markers. So as to characterise the disorder in an organotypic model, an epidermis equivalent (3D)
was developed using N/TERT-1 keratinocyte. In this model, LOX down-regulation did not
interfere with stratification, nor with early differentiation steps. Nevertheless, terminal
differentiation was strongly impaired, as observed by the absence of stratum corneum,
concomitantly to a decrease in late differentiation markers expression. Taken together, these
results suggest that dysregulation of LOX has dramatical consequences onto epidermis terminal
differentiation process.
P10
Neuronal growth of a sensory-like neuronal cell line in co-culture with a human
skin explant
N Lebonvallet1, C Jeanmaire2, L Danoux2, G Pauly2, A Rathjens2 and L Misery1. 1EA4326,
Universite´ Europe´enne de Bretagne, Universite´ de Brest and 2Cognis France, Division
Laboratoires Se´robiologiques, Pulnoy, France
Nerve growth and the recovery of sensitivity following a traumatic injury of human beings
(amputation, burns, and graft) is long and often partial. The role of growth factors and the process
of neuronal growth are crucial. We have developed an in vitro model of co-culture of human skin
explant with a rat neuronal cell line presenting some characteristics of sensory neurons (PC12).
This model allowed us an observation of the growth of nerve fibers in response to mediators
produced by the explant. For eight days, we measured every two days the length of nerve fibers
from our cells in the presence or absence of explant. We also measured the length of nerve fibers
in the presence of a complement used for the cultivation of primary neuronal cells (B27). From the
fourth days, the average length of neurites was greater in the presence of the explant, the
difference becoming significant at six and eight days. The B27, however, partially inhibited this
effect. These measures show the influence of explant on the nerve cells in a simple way. This
work allows us to perform other studies on the essential factors necessary for the neuronal growth
in a peripheral organ such as the skin.
P11
Ultrastructural demonstration of the link between acquired cutis laxa and
monoclonal gammopathy
A Maruani1,2, B Arbeille1,3, M-C Machet1,4, C Barbet1,5 and L Machet1,2. 1Universite´ Franc¸ois
Rabelais Tours, Services de; 2Dermatologie; 3Microscopie Electronique; 4Anatomie Pathologique
and 5Ne´phrologie, CHRU Tours, France
Cutis laxa is an uncommon disorder than can be acquired and has been reported to be associated
with myeloma in few cases (1,2). A causal link between paraprotein and acquired cutis laxa has
been suggested as direct immunofluorescence revealed deposition of IgG around elastic fibers in
the dermis in several cases. A 34-year-old man developed laxity of the skin, starting from the
eyelids, which spread for 2 years until it involved almost the entire skin. Lab results showed
monoclonal IgG lambda gammopathy 3.3 g/l. Electron microscopy revealed that the elastic fibres
of the reticular dermis were shortened and fragmented, with abundant microfibrillar component,
contrasting with normal collagen bundles. An immunogold labelling revealed anti-lambda
antibodies binding to the microfibrillar component of elastic fibers. This is the first observation
demonstrating the binding of monoclonal gammopathy to elastic fibers with electron microscopy.
Binding of the monoclonal paraprotein to elastic fibres may probably induce their fragmentation.
(1) Fre´mont G, et al. Cutis laxa ge´ne´ralise´e associe´e a` un mye´lome: de´couverte de grandes
cellules vacuolise´es dermiques. Ann Dermatol Venereol 2007; 134:548–51.
(2) Ting HC, et al. Acquired cutis laxa and multiple myeloma. Br J Dermatol 1984; 110:363–7.
P12
LBR mutation in systemic sclerosis
C Gaudy-Marqueste1,2, P Roll2, P Cau2, J-J Grob1, N Levy2 and A de Sandre2. 1Service de
Dermatologie Hoˆpital Ste Marguerite and 2Inserm UMR-S910, Universite´ Aix-Marseille II., France
Lamins are proteins of the nuclear envelope involved in ‘‘laminopathies’’, diseases sharing
clinical similarities with Systemic Sclerosis (SSc). In this context, we searched for mutations in
LMNA, encoding Lamins A/C, and ZMPSTE24, LBR, LMNB1, LMNB2, MAN1, NES1 and TMPO,
encoding Lamins A/C molecular partners, in a Caucasian woman affected with CREST syndrome.
Coding regions and intron-exon boundaries of these genes were PCR-amplified and sequenced,
revealing a heterozygous missense mutation in exon 9 of LBR (c.1114C4T; R372C). This variant
was absent in 100 controls and 30 other SSc patients. Several sequence polymorphisms were
found throughout the LBR gene as well as in MAN1 and NES1 while wild type sequences were
observed for the other genes. Pelger Huet anomaly was excluded by granulocyte’s lobulation
analysis. Arginine 372 residue was highly conserved throughout evolution. The mutation was
predicted to induce a change in LBR tertiary structure by bioinformatics tools. Functional
explorations were performed on patient’s fibroblasts. Western Blots showed an impressive
reduction of LBR, Lamin A/C and LMNB2 expression, together with abolished expression of
LMNB1 and HP1a. Immunocytochemical explorations displayed normal LBR localisation but
reduced Lamin A specific staining with abnormal distribution of Lamin B1, Lamin B2 and HP1.
Our results suggest that the LBR mutation, inducing both LBR reduced expression levels and
structural modifications of the residual protein, might have a downstream deleterious effect on
several molecular partners known to closely and functionally interact in cell nuclei. LBR




An anti-inflammatory effect of extracts of Bacteroides thetaiotaomicron in a
cutaneous murine model
A-C Hochart-Behra1,2,3, E Rousseau4, M-L Reynaert1,2, S Vernel1, B Gressier3,5, M Luyckx5,
T Dine5, C Brunet5, L Dubreuil1 and J Behra-Miellet1,2. 1Laboratoire de Bacte´riologie Clinique,
Faculte´ de Pharmacie de Lille, Universite´ Lille Nord de France, France; 2EA 1043; 3Laboratoire
CH d’Armentie`res, France; 4Service d’Anatomo-Pathologie, CH de Mouscron, Belgique, and
5Laboratoire de Pharmacologie, Faculte´ de Pharmacie de Lille, Universite´ Lille Nord de France,
Lille, France
B. thetaiotaomicron, a commensal anaerobe would rather be favourable for the human organism
by its anti-inflammatory effect. We recently developed a cell-free extract of this bacterial species
containing stress enzymes. It strongly inhibits the O2
 produced by the xanthine/xanthine-oxydase
system. A murine model of cutaneous irritation enabled us to show whether the extract exerted its
anti-oxidant potential in vivo. The mice underwent an ear irritation by benzalkonium chloride.
Each batch of mice (n¼ 9–10) was then treated by local application of the extract, vehicle of this
extract, NaCl 9%, hydrocortisone 100mg/ml and no treatment (positive control). A negative
control without irritation was tested in parallel. The ear thickness was measured by a digital
electronic micrometer every hour for 5 hours. The data was analysed by ANOVA. Histological
slices were made from ears of some animals sacrificed at T¼ 2 hours. Haematoxylin-Eosin-Safran
and Giemsa staining were then used to determine the percentage of degranulating mast cells in
each ear. The positive control ears showed a maximal edema at T¼2 hours. An antiphlogistic
effect of the extract was observed. It was more important than that of hydrocortisone. A lower
mast cell degranulation was shown for the mice treated by the extract than for the positive
controls. Various mechanisms could be involved in this anti-inflammatory effect, including the
inhibition of reactive O2 species.
P14
Evaluation of CETAVLONs’s bacteriostatic power of the skin flora on the hands.
Proof of concept study
C Roques1, S Brousse2, C Panizutti2, J Theunis3 and C Nguyen3. 1Universite´ de Toulouse, UPS LU
49; 2Fonderephar, Toulouse and 3Laboratoires Pierre Fabre, Toulouse, France
Aims: The aim of our study was to assess the quantitative and qualitative evolution of the normal
skin flora after the use of a topical antibacterial (CETAVLON cre`mes). Methods: Hands skin flora
analysis in a monocentric, open, randomized study with 30 healthy volunteers. After
randomization, a sample of one hand (control) skin flora was performed, followed by product
application on the other hand, with samples after 5 and 60 minutes. The identification was
performed taking into account the bacterial groups: aerobics, anaerobes, Gram þ , Gram ,
bacilli, cocci. Results: 24 subjects were included, 54.17% were women, mean age of 53.10 (min
23.19 –max 64.15). Statistical analysis of microbiological results indicated a significant reduction
of aero-anaerobes flora between T0-T5 and T0–T60 (represented mainly by cocci and
Gramþ bacilli) and aerobic flora (Gramþ cocci). At T60, a gradual and significant recolonization
is noticed, specially for the most representative group (GramþCocci). The local tolerance is rated
very good un 100% of cases. Conclusion: This study has showed a real antibacterial effectiveness
of the product in vivo, under the use conditions, justifying its use in the additional treatment of
bacterial diseases and limiting secondary infections. The observed effectiveness is immediate and
characterized by remanent effect, without evidence of significant imbalance of the skin flora.
P15
The caucasoid/negroid switch is associated with a proliferation/differentiation
imbalance in a human xenograft model
M Cario-Andre, C Pain, G Delia, D Masia and V Casoli, A Taieb INSERM U876; University V.
Segalen and Departments of Dermatology and Surgery, Bordeaux University Hospitals, Bordeaux,
France
Using a xenograft model, we have previously demonstrated that murine fibroblasts induce an
increase in human epidermal pigmentation. This change in epidermal pigmentation strongly
suggested that murine dermal influences could switch an original caucasoid pigmentation system
into a negroid one. To analyze this phenomenon we have grafted low phototype human skin on
20 nude mice and we have taken skin biopsies at different time points to follow pigmentation
changes parallel to macroscopic observations. We confirmed that in pigmented samples melanin
was increased in all layers and that melanosomes were fully melanized and never grouped as in
negroid epidermis. Surprisingly, fully melanized and non grouped melanosomes were also found
in basal and suprabasal layers in macroscopically white skin. This change in pigmentation was
associated with the expression of proliferation markers (p63). We observed that involucrin was
expressed in granular and superficial spinous layers in non pigmented samples whereas it was
expressed in all the layers in pigmented samples. As compared with donor skin, loricrin
expression was unchanged whereas filaggrin expression was distured in some samples. This
change in pigmentation seemed unrelated to dermal inflammation since we observed no infiltrate
in the dermis and no increased number of murine CD3 positive cells. In conclusion, our data
based on a murine model, support the hypothesis that dermal factors may regulate the caucasoid/
negroid switch in the human epidermal melanin unit by modifying the proliferation/differentiation
balance.
P16
Asymmetric distribution of EGFR in mitotic keratinocytes: EGFR negative A431
cells constitute a reservoir of cancer keratinocytes with reproductive potential
H Le Roy, P Formstecher and R Polakowska. Inserm U837, JPA Research Center, 1 Place de
Verdun, 59045 Lille Cedex, France
Cancer cells are phenotypically and functionally unequal in a tumor mass and in established
cultures. This is attributable to a small subpopulation of cancer stem cells with the unique ability
to generate differentiating progeny while maintaining a steady state number. Regulation of this
dual ability is controlled at the level of asymmetric division by mechanisms that are yet not well
defined. We found that normal and A431 squamous cell carcinoma keratinocyte fate was linked
to the asymmetric distribution of epidermal growth factor receptor (EGFR) during mitosis. Indeed,
though essential for epithelial cell proliferation, differentiation and survival, this receptor was not
present on the surface of cells satisfying criteria for stem cells such as quiescence, competence to
produce two functionally distinct daughters, high proliferative and clonogenic potential, sphere
formation ability and expression of stem cell markers. In contrast, keratinocytes displaying EGFR
acquired a more differentiated phenotype, implying that EGFR controls a switch from stem to
transient amplifying cell fate. This switch was associated with changes in the expression profile of
cell cycle, survival and mitochondria controlling proteins that varied between normal and cancer
cells underlying differences in EGFR function at the key point of the phenotypic switch. In
conclusion, our data indicate that keratinocytes fate is controlled by an unequal distribution of
EGFR at mitosis that appears to balance cellular quiescence and proliferation, clearly
malfunctioning in cancer. We believe that our findings may provide mechanistic insights into
the relative inefficacy of current anti-EGFR therapies.
P17
Probing tumour and peritumoral tissues in superficial and nodular basal cell
carcinoma using polarized Raman microspectroscopy
E Ly1, A Durlach2, F Antonicelli3, P Bernard3,4, M Manfait1 and O Piot1*. 1Me´DIAN UMR CNRS
6237 MEDyC, URCA, Reims; 2Laboratoire Pol Bouin, CHU Maison-Blanche, Reims; 3Laboratoire
de Biochimie et de Dermatologie UMR CNRS 6237 MEDyC, URCA, Reims and 4Service de
Dermatologie, CHU Robert Debre´, Reims, France
Basal cell carcinoma (BCC) can sometimes lead, through a possible invasion of the dermis and the
subcutaneous tissue, to serious local damage to the patient. Several histological types of BCC are
reported, among them, the superficial, nodular, and infiltrative forms. This study reports the use of
polarized Raman microspectroscopy on the nodular and superficial types to discriminate between
healthy epidermis and tumour, and between normal and peritumoral stroma. This technique
probes additional information than conventional Raman spectroscopy because it is sensitive to
the molecular ordering of tissue components. Depolarization ratios and hierarchical cluster
analysis demonstrate that polarized Raman microspectroscopy can better identify the tumour and
the peritumoral dermis than conventional Raman microspectroscopy, and hence gives potential
complementary data about their molecular characteristics (molecular composition, secondary
structure of proteins, intra- and/or inter-molecular bonding). Our findings also show that although
superficial and nodular types of BCC were analyzed, clear differences between the spectra of
peritumoral and normal dermis could be detected.
P18
IL-8 increases TIMP-1/-2 expression and reduces melanoma cells invasiveness
S Demissy1, W Hornebeck2, P Bernard1 and F Antonicelli1. 1Laboratoire de Dermatologie and
2Laboratoire de biochimie et biologie mole´culaire; UMR CNRS-6237, UFR me´decine, URCA,
Reims, France
We previously demonstrated in our laboratory that melanoma cells treated with elastin-derived
fragments increased MMP-2 expression as well as cytokine secretion such as IL-1beta and IL-8
(1, 2). To gain insight into melanoma invasion, we investigated whether treatment of melanoma
cell with IL-8 generated an amplification loop mechanism. Using an in vitro invasion test, we
found that IL-8 treatment did not increase melanoma invasion as measured by cell migration
through a coat of matrigel, whereas we observed an increase in MMP-2 and MMP-9 expression.
We therefore investigated the role of MMPs activation in this process. In our model both the pro
and the activated forms of MMP-2/-9 enhanced melanoma cell invasion. However, co-treatment
with IL-8 reduced the effects of added MMPs on melanoma cell migration in vitro. To investigate
the mechanisms by which IL-8 reduced MMPs-driven melanoma cell invasion, we determined
the effects of IL-8 on MMPs inhibitors, and observed an increase of both TIMP-1/-2 expressions.
This inhibitory effect of IL-8 on melanoma invasion was further confirmed on another melanoma
and non-skin cancer cell lines. Hence, we showed here that the pro-tumoral effect of IL-8 in vivo
might require paracrine mechanisms.
(1) Debret et al. Journal of Investigative Dermatology 2006; (1860–1868).
(2) Baranek et al. The Journal of Immunology 2008; (6184–6192).
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Propolis extract decreases oxidative stress but not cell death induced by
doxorubicin in melanoma cells
L Benguedouar1,3, H El Btaouri2, M Lahouel3, P Bernard1 and F Antonicelli1. 1Laboratoire de
Dermatologie, UMR CNRS-6237, UFR me´decine, URCA, Reims, France; 2Laboratoire SIRMA,
UMR CNRS-6237, UFR Sciences, URCA, Reims, France and 3Laboratoire de pharmacologie &
phytochimie, faculte´ des Sciences, Universite´ de Jijel, Alge´rie
Propolis is a natural honeybee product resinous and dark coloured, gathered by bees from leaf
buds of various tree species. We recently demonstrated that propolis extract protected heart and
liver tissues from oxidative stress by protecting the mitochondria. Besides, it has also been shown
that propolis induced cytotoxicity effects in human melanoma and that these effects were
comparable to doxorubicin, a clinical anticancer drug. Then, we wondered whether propolis
extract would affect positively or negatively doxorubicin-induced toxicity by reducing oxidative
stress in melanoma cells. In this study, we first confirmed that propolis extract inhibited
significantly from a concentration of 5 mg/ml superoxide anion O2
1 production from isolated
mitochondria. We then demonstrated that propolis extract had a strong capability to scavenge
O2
1 production using the WST-1 test on human and murine cultured melanoma cells.
Additionally, propolis extract at 10 mg/ml exhibited a cytotoxic effect on melanoma cells
comparable to doxorubicin used at 3 mM. However, although the combined effects of propolis
extract and doxorubicin reduced mitochondria O2
1 production, co-treatment of melanoma cells
with propolis extract did not protect from doxorubicin-induced cell death. These results suggest
that mechanisms not dependent on the production of ROS are involved in doxorubicin induced
apoptosis in melanoma cells.
P20
ANNEXIN A1 (ANXA1) modulates melanoma B16 line invasion
F Rondepierre1, B Bouchon1, J Papon1, M Bonnet-Duquennoy1, N Moins1, JM-Chezal1,
M D’Incan1,2 and F Degoul1. 1EA4231 Universite´ d’Auvergne Clermont-1, and 2Dermatologie,
CHU Hoˆtel-Dieu, Clermont-Ferrand, France
Aim: To characterize proteins involved in melanoma spreading in order to identify new
therapeutic targets and/or new prognostic markers. Material, method: Comparison of two murine
melanoma cell lines B16F10 and B16Bl6 with different metastasis behaviour: in vivo, after
cutaneous grafting, only B16Bl6 induces pulmonary metastasis. Using MALDI-TOF, we have
previously identified differential expressing proteins between these two cell lines in vitro, and
in vivo from murine tumours. Results: Among these proteins, ANXA1 is overexpressed in the
metastasis cell line Bl6. Down expression of ANXA1 using small interferent RNA reduced Bl6
invasion in Matrigel. We have shown using qRT-PCR that Formyl Peptid Receptors (FPR), which
are the natural ligands of ANXA1, were expressed in Bl6 lines. Down or up regulation of FPR
expression, using antagonist or agonists, modulated ANXA1 expression and Bl6 invasion in
Matrigel suggesting that these receptors are effective (Rondepierre F et al. BBA Proteomics, 2009).
These data were confirmed in vivo: in C57Bl6 mouse engrafted with Bl6 cells, intra tumoral
injection of anti-ANXA1 siRNA significantly reduced pulmonary metastases number. Conclusion:
Our data suggest that in this animal model, ANXA1 modulates melanoma spreading, probably
through an interaction with their ligand (FPR). Now we are focussing our work on in vitro FPR
modulation in order to verify this hypothesis.
P21
In vivo expression of ANNEXIN A1 (ANXA1): a prognostic marker for melanoma?
F Rondepierre1, R Kintossou-Mathieu2, F Franck3, S Mansard2, J Joubert3, B Bouchon1,
P De´chelotte3, P Souteyrand2, F Degoul1 and M D’Incan1,2. 1EA4231 Universite´ d’Auvergne
Clermont-1, 63005; 2Dermatologie, CHU Hoˆtel-Dieu, Clermont-Ferrand cedex 1 and 3Anatomie
Pathologie, CHU Hoˆtel-Dieu, Clermont-Ferrand, France
Background: We have previously shown that ANXA1 enhanced in vitro invasion properties of
murine B16 cells.
Aim: To evaluate the prognostic value of ANXA1 expression in melanoma tumours. Material,
methods: ANXA1 expression was immunohistochemically assessed on paraffin embedded slides
from skin melanoma tumours using a commercially available antibody. A positive expression,
number of labelled cells and distribution pattern of theses cells were correlated to overall survival
and metastasis onset. Selected tumours were old enough to allow a large follow up and their
clinical data were up dated on December 2008. Results: 38 tumours (36 patients) removed
between 1991 and 1995 were studied. Mean Breslow index was 1.89 mm (þ /1.41). Presence of
cells expressing ANXA1 was associated with an risk of visceral metastasis (OR¼ 6,
CI95%¼ [1.3–28.1]) and node metastasis (OR¼14.3, CI95%¼ [1.6–129.9]). Above all, among
thin melanomas (Bo1 mm, n¼3), only those with ANXA1 expression gave metastasis. At least,
ANXA1 expression was statistically independent from Breslow index value (P¼ 0.16). Conclusion
– Perspectives: these results obtained in vivo are in accordance with those obtained in vitro on
B16 murine melanoma lines and suggest that ANXA1 could play a role in melanoma spreading.
We are now prospectively evaluating ANXA1 expression as prognostic factor, especially in thin
melanomas.
P22
B16 Melanoma secretomes and in vitro invasiveness: syntenin as an invasion
modulator
F Rondepierre1, B Bouchon1, M Bonnet-Duquennoy1, N Moins1, J-M Chezal1, M D’Incan1,2 and
F Degoul1. 1EA4231 Universite´ d’Auvergne Clermont-1, Clermont-Ferrand cedex and 2Derma-
tologie, CHU Hoˆtel-Dieu, Clermont-Ferrand, France
Aim: To identify secreted proteins involved in melanoma metastasis process. Material, method:
Comparison of (1): using MALDI-TOF, secretomes of two murine melanoma cell lines, B16F10
and B16Bl6, with different metastasis behaviour (in vivo, after cutaneous grafting, only B16Bl6
induces pulmonary metastasis) and (2): proinvasive activity in a Matrigel system of secretomes
from Bl6 and BF10 lines by incubation of sarcoma cell line HT1080. Results: Supernatant from
Bl6 culture strongly enhanced HT1080 migration. Secretome analysis identified 18 proteins
differentially expressed between Bl6 and BF10. Among these proteins, we identified lactate
deshydrogenase B, M2 pyruvate kinase, cathepsin D and Galectin 1, proteins known to
participate to melanoma aggressiveness signature. In the less aggressive cell line BF10 secretome,
retrovial gag proteins and syntenin were over expressed. Conversely, in aggressive line, Bl6,
syntenin was predominantly found on its intracellular form. Incubation of HT1080 in BF10
supernatant treated with an anti-syntenin antibody, strongly enhanced invasion. These data were
confirmed in human cell lines M3Dau and M4Beu which, like Bl6 and BF10, have different
metastasis behaviour. Conclusion: These data suggest that syntenin participates to the cell
invasion process, may be through a balance between its intra and extra cellular forms. If
confirmed in melanoma tumours, localization of syntenin in tumour cells could be regarded as a
potential prognosis marker.
www.jidonline.org 2533
ABSTRACTS
